Alpha Xpansion · Research documentation
Find the report behind the vial.
Search by compound, strength, lot, or report number. Match the report lot to the vial label before relying on a result. Reports describe the submitted sample and their stated test scope.
9 reports
Batch documentation
BAC Water 30 ml
- Lot / batch
- EB61901
- Laboratory
- Chromate
- Report
- 35348 / EBAC444D2MUF
- Report date
- May 22, 2026 (analysis)
| Analyte | Benzyl alcohol |
|---|---|
| Reported concentration | 0.921% (specification: 0.9%) |
| Reported endotoxins | Less than 0.25 EU/mL |
| Reported pH | 6.253 |
Results transcribed from the attached report. See the original document for methods, specifications and all results.
Open original report PDF ↗ (opens in a new tab)Batch documentation
GLOW 70 mg
- Lot / batch
- T-GLO-0029
- Laboratory
- Axiom Analytics Laboratories
- Report
- AX-2026-1783-2D9J
- Report date
- October 1, 2026
| Reported component purity | GHK-Cu: 99.63%; BPC-157: 99.64%; TB-500: 99.93% |
|---|---|
| Measured sample content | GHK-Cu: 52.55 mg; BPC-157: 10.51 mg; TB-500: 10.52 mg (73.58 mg total) |
| Sample count | 1 client-submitted vial |
| Microbial DNA screen | Target DNA not detected (rapid PCR) |
| Targeted fentanyl screen | Not detected at the stated 1 ng/mg limit |
Results apply to the submitted sample. The rapid PCR screen is not a batch sterility determination. See the original report for methods, limits and full results.
Open original report PDF ↗ (opens in a new tab)Batch documentation
Glutathione 500 mg
- Lot / batch
- DPS-1818605
- Laboratory
- Horizon Analytical
- Report
- 1018082
- Report date
- July 28, 2026
| Reported purity | 99.56% |
|---|---|
| Measured sample content | 512 mg |
| Report client | Direct Peptides |
Supplier-linked report. Results apply to the submitted sample; match the report lot to your vial label.
Open original report PDF ↗ (opens in a new tab)Batch documentation
KLOW 80 mg
- Lot / batch
- T-KLO-0030
- Laboratory
- Axiom Analytics Laboratories
- Report
- AX-2026-4306-9H9U
- Report date
- October 1, 2026
| Reported component purity | GHK-Cu: 99.40%; BPC-157: 99.92%; TB-500: 99.97%; KPV: 99.48% |
|---|---|
| Measured sample content | GHK-Cu: 53.23 mg; BPC-157: 10.45 mg; TB-500: 10.35 mg; KPV: 10.24 mg (84.27 mg total) |
| Sample count | 1 client-submitted vial |
| Microbial DNA screen | Target DNA not detected (rapid PCR) |
| Targeted fentanyl screen | Not detected at the stated 1 ng/mg limit |
Results apply to the submitted sample. The rapid PCR screen is not a batch sterility determination. See the original report for methods, limits and full results.
Open original report PDF ↗ (opens in a new tab)Batch documentation
MOTS-C 40 mg
- Lot / batch
- T-MOT-0063
- Laboratory
- Axiom Analytics Laboratories
- Report
- AX-2026-3888-8KRU
- Report date
- October 1, 2026
| Reported purity | 99.88% |
|---|---|
| Measured sample content | 42.15 mg |
| Sample count | 1 client-submitted vial |
| Microbial DNA screen | Target DNA not detected (rapid PCR) |
| Targeted fentanyl screen | Not detected at the stated 1 ng/mg limit |
Results apply to the submitted sample. The rapid PCR screen is not a batch sterility determination. See the original report for methods, limits and full results.
Open original report PDF ↗ (opens in a new tab)Batch documentation
NAD+ 1000 mg
- Lot / batch
- T-NAD-0068
- Laboratory
- Axiom Analytics Laboratories
- Report
- AX-2026-3456-2CAJ
- Report date
- October 1, 2026
| Reported purity | 99.72% |
|---|---|
| Measured sample content | 1069.22 mg |
| Sample count | 1 client-submitted vial |
| Microbial DNA screen | Target DNA not detected (rapid PCR) |
| Targeted fentanyl screen | Not detected at the stated 1 ng/mg limit |
Results apply to the submitted sample. The rapid PCR screen is not a batch sterility determination. See the original report for methods, limits and full results.
Open original report PDF ↗ (opens in a new tab)Batch documentation
Selank 10 mg
- Lot / batch
- TP260630
- Laboratory
- Accumark Labs
- Report
- BFM9-T3F6
- Report date
- July 29, 2026
| Reported purity | 99.917% |
|---|---|
| Declared sample size | 10.0 mg |
| Measured sample content | 13.47 mg |
| Report client | Research Vault |
Supplier-linked report. Results apply to the submitted sample; match the report lot to your vial label.
Open original report PDF ↗ (opens in a new tab)Batch documentation
Semax 10 mg
- Lot / batch
- TP260630
- Laboratory
- Accumark Labs
- Report
- 3MP7-LAMC
- Report date
- July 30, 2026
| Reported purity | 99.697% |
|---|---|
| Declared sample size | 10.0 mg |
| Measured sample content | 6.29 mg |
| Report client | Research Vault |
Report note: Content discrepancy: this COA lists 10 mg declared content and 6.29 mg measured in the submitted sample. This result does not establish the content of every vial; confirm the applicable lot with the supplier and laboratory.
Supplier-linked report. Results apply to the submitted sample; match the report lot to your vial label.
Open original report PDF ↗ (opens in a new tab)Batch documentation
SS-31 10 mg
- Lot / batch
- T-SS3-0016
- Laboratory
- Axiom Analytics Laboratories
- Report
- AX-2026-3357-YX3D
- Report date
- October 1, 2026
| Reported purity | 99.88% |
|---|---|
| Measured sample content | 10.51 mg |
| Sample count | 1 client-submitted vial |
| Microbial DNA screen | Target DNA not detected (rapid PCR) |
| Targeted fentanyl screen | Not detected at the stated 1 ng/mg limit |
Results apply to the submitted sample. The rapid PCR screen is not a batch sterility determination. See the original report for methods, limits and full results.
Open original report PDF ↗ (opens in a new tab)No reports match your search. Try a compound name or lot number.